Literature DB >> 9081706

In vitro targeting and specific transfection of human neuroblastoma cells by chCE7 antibody-mediated gene transfer.

J L Coll1, E Wagner, V Combaret, K Metchler, H Amstutz, I Iacono-Di-Cacito, N Simon, M C Favrot.   

Abstract

We developed a new vector for gene targeting of neuroblastoma (NB) cells, based on the utilization o a monoclonal antibody (chCE7) covalently linked to polylysine (PL). In the presence of chloroquine, chCE7-PL-DNA complexes transfected NB cells as efficiently as DOTAP, transfectam, TF-X50, or lipofectamine. This was demonstrated by transfection of the luciferase or beta-galactosidase reporter genes in three different NB cell lines. This transfection was specific, since it was inhibited in the presence of competing unconjugated chCE7 antibody (Ab), and was not observed in cell lines negative for the CE7 antigen. We tested the potential biological activity of a plasmid coding for gamma-interferon (gamma IFN) transfected with chCE7-PL. HLA ABC expression on NB cells was induced after transfection with pCMV-gamma IFN at a higher level than after incubation with 1000 IU/ml of purified gamma IFN. Moreover, these HLA ABC-positive NB cells were able to activate autologous cytotoxic T lymphocytes in vitro. Thus chCE7-PL is able to target a plasmid to NB cells and to allow the expression of the transfected gene in a biologically active form.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9081706     DOI: 10.1038/sj.gt.3300375

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  5 in total

Review 1.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 2.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

3.  Fabrication of DNA-antibody-apatite composite layers for cell-targeted gene transfer.

Authors:  Yushin Yazaki; Ayako Oyane; Hiroko Araki; Yu Sogo; Atsuo Ito; Atsushi Yamazaki; Hideo Tsurushima
Journal:  Sci Technol Adv Mater       Date:  2012-11-08       Impact factor: 8.090

4.  Low-dose interferon-gamma-producing human neuroblastoma cells show reduced proliferation and delayed tumorigenicity.

Authors:  I Airoldi; R Meazza; M Croce; E Di Carlo; T Piazza; C Cocco; T D'Antuono; V Pistoia; S Ferrini; M V Corrias
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

5.  Targeted gene transfer for adenocarcinoma using a combination of tumor-specific antibody and tissue-specific promoter.

Authors:  S Kurane; J C Krauss; E Watari; R Kannagi; A E Chang; S Kudoh
Journal:  Jpn J Cancer Res       Date:  1998-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.